Disease Info Card

Glycogen Storage Disease Type I

Information about Glycogen Storage Disease Type I: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Glycogen Storage Disease Type I

Most recent studies have shown that Glycogen Storage Disease Type I shares some biological mechanisms with acidosis, adenoma, carcinoma, glucose-6-phosphate-transport-defect, glucosephosphate-dehydrogenase-deficiency, glycogen-storage-disease, glycogen-storage-disease-type-iii, hepatomegaly, hyperlipidemia, hyperuricemia, hypoglycemia, inborn-errors-of-metabolism, infective-disorder, kidney-diseases, liver-carcinoma, liver-diseases, liver-neoplasms, metabolic-diseases, neoplasms, storage-disease.

Among the many pathways, these few ones have gauged particular interests from scientists studying Glycogen Storage Disease Type I, and have been seen in publications frequently: Bone Maturation, Chemotaxis, Excretion, Fatty Acid Oxidation, Glomerular Filtration, Gluconeogenesis, Glucose Homeostasis, Glucose Transport, Glucose-6-phosphate Transport, Glycolysis, Glycosylation, Insulin Secretion, Localization, Neutrophil Chemotaxis, Pathogenesis, Phagocytosis, Respiratory Burst, Secretion, Transport, Urea Cycle

Quite a number of genes have been found to play important roles in Glycogen Storage Disease Type I, such as AFP, ALB, ATP8A2, BTD, CSF2, CSF3, G6PC, G6PC3, G6PD, GCG, INS, PHKA2, SLC25A5, SLC37A4, UBL4A. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.